Episode 361: The Role of Monotherapy AR Inhibition in Prostate Cancer

Our latest episode with special guest Bertrand Tombal of Manchester Cancer Research Centre focuses on the historic and current data of AR inhibition and monotherapy with AR blockers.

The effects of enzalutamide and results of the EMBARK study are also discussed.